title: A new heterotopic transplant animal model of intestinal fibrosis.
abstract: BACKGROUND
  Severe mucosal tissue damage requiring efficient wound healing is a main feature of inflammatory bowel disease but excessive tissue repair promotes fibrosis. The clinical investigation of fibrosis is confined to the limited amount of biological material available from patients. This makes the establishment of a new animal model, a highly desirable goal. We investigated whether intestinal fibrosis occurs after heterotopic transplantation of small bowel resections in rats.
  
  
  METHODS
  Donor (Brown Norway or Lewis rats) small bowel resections were transplanted subcutaneously into the neck of recipients (Lewis rats). Grafts were explanted 2, 7, 14, and 21 days after transplantation.
  
  
  RESULTS
  Heterotopic intestinal transplants remained viable for 21 days. Rapid loss of crypt structures at day 2 after intestinal transplantation was followed by lymphocyte infiltration and obliteration of the intestinal lumen by fibrous tissue at day 21. Loss of the intestinal epithelium was confirmed by the lack of cytokeratin staining in immunohistochemistry. Collagen expression was increased with time after transplantation as confirmed by real-time PCRs, Elastica van Gieson, and Sirius Red staining. Lumen obliteration was connected with increased expression of potent mediators of fibrosis such as α5β6 integrin, interleukin (IL)-13, and transforming growth factor β. Myofibroblast phenotype was demonstrated by the presence of both α-smooth muscle actin and vimentin in the obliterated lumen.
  
  
  CONCLUSIONS
  We established a method for heterotopic transplantation of small bowel resections. A variety of histologic and molecular features of fibrosis were observed in the heterotopic intestinal grafts which suggests, that this new in vivo model will be instrumental in studying pathogenesis and treatment of intestinal fibrosis.
authors.affiliation: *Department of Internal Medicine, Clinic of Gastroenterology and Hepatology, and †Division of Pulmonology, University Hospital Zürich, Zurich, Switzerland.
authors.forename: Martin
authors.initials: M
authors.lastname: Hausmann
authors.forename: Thomas
authors.initials: T
authors.lastname: Rechsteiner
authors.forename: Michaela
authors.initials: M
authors.lastname: Caj
authors.forename: Christian
authors.initials: C
authors.lastname: Benden
authors.forename: Michael
authors.initials: M
authors.lastname: Fried
authors.forename: Annette
authors.initials: A
authors.lastname: Boehler
authors.forename: Gerhard
authors.initials: G
authors.lastname: Rogler
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism*; D015153:Blotting, Western; D003094:Collagen / Q000235:genetics / Q000378:metabolism; D004195:Disease Models, Animal; D005355:Fibrosis; D005455:Fluorescent Antibody Technique; D006085:Graft Survival / Q000502:physiology*; D007124:Immunoenzyme Techniques; D007421:Intestine, Small / Q000378:metabolism / Q000473:pathology* / Q000637:transplantation*; D008297:Male; D016377:Organ Transplantation; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016042:Transplantation, Heterotopic
chemical_list: D015415:Biomarkers; D012333:RNA, Messenger; D003094:Collagen